Page 51 - Borderline News Today

By the nature of it, it needs to collect a lot of data, and that means its going to take a long time before it can actually be properly useful. i think that a follow—up - of five years for the patients included in this trial - could be informative enough to understand the - performance of the ai. within minutes of the slides being scanned, the ai will have made its assessment of the risk. in this case, its low. but when its at a more moderate level, the dilemma really exists. sometimes there i...

A long time before it can actually be properly useful. | i think that a follow—up of five j years for the patients included in this trial could be informative enough to understand _ the performance of the ai. within minutes of the slides being scanned, the ai will have made its assessment of the risk. in this case, its low. but when its at a more moderate level, the dilemma really exists. sometimes there is a grey zone and some cases are borderline. so maybe not completely good prognosis, mayb...

Be properly useful. i think that a follow—up - of five years for the patients included in this trial could be informative enough- to understand the - performance of the ai. within minutes of the slides being scanned, the ai will have made its assessment of the risk. in this case, its low. but when its at a more moderate level, the dilemma really exists. sometimes there is a grey zone and some cases are borderline. so maybe not completely good prognosis, maybe not completely bad. and in this gr...

Made its assessment of the risk. in this case, its low, but when its at a more moderate level, the dilemma really exists. sometimes, there is a grey zone and some cases are borderline, so maybe not completely good prognosis, maybe completely bad. and in this grey zone, we need other tools to decide for the prognosis of the patient. and here, we have the information that you receive after the als looked at the data. exactly. so here, for example, i can see that the ai risk is low — its a low—...

Digitising slides isnt a new concept, but running an ai model to determine the risk of cancer returning is. no—one involved is suggesting that this will replace the importance of doctors, but the hope is that more detailed data and analysis could enhance theirjudgement calls. within minutes of the slides being scanned, the ai will have made its assessment of the risk. in this case, its low, but when its at a more moderate level, the dilemma really exists. sometimes there is a grey zone and som...

With what i saw on the microscope. by the nature of it, it needs to collect a lot of data, and that means its going to take a long time before it can actually be properly useful. | i think that a follow—up of five j years for the patients included in this trial could be informative enough to understand _ the performance of the ai. within minutes of the slides being scanned, the ai will have made its assessment of the risk. in this case, its low. but when its at a more moderate level, the dilem...

And that means its going to take a long time before it can actually be properly useful. | i think that a follow—up of five j years for the patients included in this trial could be informative enough to understand _ the performance of the ai. within minutes of the slides being scanned, the ai will have made its assessment of the risk. in this case, its low. but when its at a more moderate level, the dilemma really exists. sometimes there is a grey zone and some cases are borderline. so maybe no...

Means its going to take a long time before it can actually be properly useful. i time before it can actually be properly useful.— time before it can actually be properly useful. i think that a five years _ properly useful. i think that a five years of _ properly useful. i think that a five years of the _ properly useful. i think that a five years of the patients - five years of the patients included with this study could be informative enough to understand the performance of the ai. within min...

Being scanned, the ai will have made its assessment of the risk. in this case, its low, but when its at a more moderate level, the dilemma really exists. sometimes there is a grey zone and some cases are borderline, so maybe not completely good prognosis, maybe not completely bad. and in this grey zone, we need other tools to decide for the prognosis of the patient. and here we have the information that you receive after the als looked at the data. exactly. so, here, for example, i can see that ...

This helps both preserve it and keep it in place. then, instead of it being put under a microscope, its taken from the lab to a digital scanner, where a very high—resolution image of the cancerous cells is created. digitising slides isnt a new concept, but running an ai model to determine the risk of cancer returning is. no—one involved is suggesting that this will replace the importance of doctors, but the hope is that more detailed data and analysis could enhance theirjudgement calls. with...